SUBSCRIBE
SUBSCRIBE
News   Policy

Lundbeck Inc. (formerly Ovation Pharmaceuticals) Shares Drop as Drug Hits FDA Snag

June 26, 2009 | 
1 min read
Bookmark and Share

Reuters -- Shares in Danish pharmaceuticals group H Lundbeck A/S fell on Friday on concerns over U.S. prospects for its candidate drug for schizophrenia, Serdolect.

Regulatory Europe
Lundbeck Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Podcast
FDA Layoffs, 200 Rejection Letters, User Fees and Priority Vouchers, Bad Week for Rare Disease
July 16, 2025
 · 
1 min read
 · 
Heather McKenzie
Entrance to the U.S. Department of Health and Human Services in Washington, DC
Layoffs
HHS Begins Formally Laying Off Employees
July 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Policy
FDA Commissioner Marty Makary Proposes Lowering Industry User Fees
July 15, 2025
 · 
2 min read
 · 
Tristan Manalac
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
 · 
6 min read
 · 
Lori Ellis